Some studies found that the expression of ADH1C was significantly downregulated in hepatocellular carcinoma tumor samples compared with normal liver samples and whose high expression of ADH1C was significantly associated with a good survival rate in liver cancer patients (Chen et al., 2020; Liu et al., 2020). Here, ADH1C is linked to liver cancer.